11-45811295-C-A
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBS1_Supporting
The NM_018389.5(SLC35C1):c.1055C>A(p.Pro352His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000191 in 1,556,212 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P352S) has been classified as Likely benign.
Frequency
Consequence
NM_018389.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC35C1 | ENST00000314134.4 | c.1055C>A | p.Pro352His | missense_variant | 2/2 | 1 | NM_018389.5 | ENSP00000313318.3 | ||
SLC35C1 | ENST00000442528.2 | c.1016C>A | p.Pro339His | missense_variant | 3/3 | 1 | ENSP00000412408.2 | |||
SLC35C1 | ENST00000526817.2 | c.1016C>A | p.Pro339His | missense_variant | 3/3 | 2 | ENSP00000432145.2 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152210Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000926 AC: 18AN: 194422Hom.: 0 AF XY: 0.0000842 AC XY: 9AN XY: 106860
GnomAD4 exome AF: 0.000200 AC: 281AN: 1404002Hom.: 0 Cov.: 36 AF XY: 0.000190 AC XY: 132AN XY: 694092
GnomAD4 genome AF: 0.000105 AC: 16AN: 152210Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74352
ClinVar
Submissions by phenotype
Leukocyte adhesion deficiency type II Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 06, 2022 | This sequence change replaces proline, which is neutral and non-polar, with histidine, which is basic and polar, at codon 352 of the SLC35C1 protein (p.Pro352His). This variant is present in population databases (rs200843978, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with SLC35C1-related conditions. ClinVar contains an entry for this variant (Variation ID: 391722). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 11, 2021 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 10, 2024 | The c.1055C>A (p.P352H) alteration is located in exon 2 (coding exon 2) of the SLC35C1 gene. This alteration results from a C to A substitution at nucleotide position 1055, causing the proline (P) at amino acid position 352 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 21, 2017 | The P352H variant in the SLC35C1 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The P352H variant was not observed at any significant frequency in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The P352H variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved in mammals. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. We interpret P352H as a variant of uncertain significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at